Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function. Read more about Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function.
Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy. Read more about Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy.
Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia. Read more about Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia.
Protein arginine methylation: from enigmatic functions to therapeutic targeting. Read more about Protein arginine methylation: from enigmatic functions to therapeutic targeting.
The Promise and Peril of Chemical Probe Negative Controls. Read more about The Promise and Peril of Chemical Probe Negative Controls.
Structure and activation mechanism of the human liver-type glutaminase GLS2. Read more about Structure and activation mechanism of the human liver-type glutaminase GLS2.
Structure and Inhibitor Binding Characterization of Oncogenic MLLT1 Mutants. Read more about Structure and Inhibitor Binding Characterization of Oncogenic MLLT1 Mutants.
Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A Review. Read more about Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A Review.
Structural basis for RNA 3'-end recognition by the PIWIL2 PAZ domain. Read more about Structural basis for RNA 3'-end recognition by the PIWIL2 PAZ domain.
Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells. Read more about Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells.
